Target intelligence / Profile preview

T-cell receptor (TCR) recognizing rotavirus-derived peptides presented on MHC molecules (RV-specific TCR)

Target
RV-specific TCR
Molecular classification
Receptor, Immunoglobulin superfamily, Heterodimeric protein complex
01

Overview

T-cell receptors (TCRs) recognizing rotavirus-derived peptides are specialized protein complexes on the surface of T lymphocytes that play a pivotal role in the adaptive immune response against rotavirus infections (Angel et al., 2007). These receptors identify specific viral protein fragments, such as those from the VP6 inner capsid or NSP4 enterotoxin, which are presented by Major Histocompatibility Complex (MHC) molecules on infected cells (Nielsen et al., 2015). This recognition event triggers T-cell activation, leading to the secretion of antiviral cytokines like interferon-gamma and the direct lysis of infected enterocytes by cytotoxic T cells (Lappalainen et al., 2015). In clinical practice, the activity of these TCRs is primarily modulated through live-attenuated vaccines, which aim to establish a memory T-cell population capable of rapid response upon re-exposure (UniProt Consortium, 2023). Furthermore, the characterization of these specific TCRs is vital for developing adoptive T-cell therapies for immunocompromised individuals who cannot clear the virus naturally. Understanding the structural basis of this interaction also helps in monitoring vaccine-induced immunity and identifying potential cross-reactivity with self-antigens.

Other names
Rotavirus-specific T-cell receptorRV-specific TCRT-cell receptorTCR
02

Mechanism of action

The TCR complex recognizes specific rotavirus peptide-MHC complexes, triggering a signaling cascade through the CD3 subunits and ZAP-70 kinase, which leads to T-cell activation, proliferation, and the release of effector molecules like perforin, granzymes, and IFN-gamma (PubMed: 17556589).

03

Biological functions

Immune responseAntigen recognitionT-cell activationCell-mediated cytotoxicityCytokine production
04

Disease associations

InfectionGastroenteritis
05

Safety considerations

Molecular mimicry between rotavirus epitopes and self-antigensCytokine release syndrome (CRS) in adoptive cell therapiesHLA restriction limiting therapeutic applicabilityImmune evasion via viral mutation
06

Interacting drugs

Rotavirus Vaccine Live Oral (Rotarix)

5 more in the full profile.

07

Biomarkers

MHC-peptide multimers (tetramers/pentamers)Interferon-gamma (IFN-γ) production levelsTCR V-beta (TRBV) repertoire analysisCD137 (4-1BB) expression

Beyond the preview

Go deeper on T-cell receptor (TCR) recognizing rotavirus-derived peptides presented on MHC molecules (RV-specific TCR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T-cell receptor (TCR) recognizing rotavirus-derived peptides presented on MHC molecules (RV-specific TCR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call